Skip to main content
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy logoLink to Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
. 2015 Jan 12;19(1):5–25. doi: 10.1111/hex.12337

A review of current practices to increase Chlamydia screening in the community – a consumer‐centred social marketing perspective

Lyn Phillipson 1,, Ross Gordon 2, Joanne Telenta 1, Chris Magee 1, Marty Janssen 3
PMCID: PMC5055217  PMID: 25580560

Abstract

Background

Chlamydia trachomatis is one of the most frequently reported sexually transmitted infections (STI) in Australia, the UK and Europe. Yet, rates of screening for STIs remain low, especially in younger adults.

Objective

To assess effectiveness of Chlamydia screening interventions targeting young adults in community‐based settings, describe strategies utilized and assess them according to social marketing benchmark criteria.

Search strategy

A systematic review of relevant literature between 2002 and 2012 in Medline, Web of Knowledge, PubMed, Scopus and the Cumulative Index to Nursing and Allied Health was undertaken.

Results

Of 18 interventions identified, quality of evidence was low. Proportional screening rates varied, ranging from: 30.9 to 62.5% in educational settings (n = 4), 4.8 to 63% in media settings (n = 6) and from 5.7 to 44.5% in other settings (n = 7). Assessment against benchmark criteria found that interventions incorporating social marketing principles were more likely to achieve positive results, yet few did this comprehensively. Most demonstrated customer orientation and addressed barriers to presenting to a clinic for screening. Only one addressed barriers to presenting for treatment after a positive result. Promotional messages typically focused on providing facts and accessing a testing kit. Risk assessment tools appeared to promote screening among higher risk groups. Few evaluated treatment rates following positive results; therefore, impact of screening on treatment rates remains unknown.

Discussion

Future interventions should consider utilizing a comprehensive social marketing approach, using formative research to increase insight and segmentation and tailoring of screening interventions. Easy community access to both screening and treatment should be prioritized.

Keywords: Chlamydia, consumer orientation, screening, sexual health, social marketing

Introduction

Chlamydia trachomatis (CT) is one of the most frequently reported sexually transmitted infections (STI) in Australia,1 the UK2 and in Europe.3 International prevalence studies highlight that sexually active adults under the age of 30 years are most at risk of infection.3 If CT is left untreated, it can lead to serious conditions such as pelvic inflammatory disease and tubal infertility in females; epididymitis, urethritis and proctitis in males.4 Reducing the rates of STIs such as Chlamydia is therefore an important public health and social priority across the world.5

The main risk factors for CT in sexually active females are as follows: age (<25 years), inconsistent use of barrier contraceptives (e.g. condoms), multiple sexual partners, cervical ectopy and a history of STI or a co‐existing STI.4 Many existing strategies to reduce infection rates have focused on awareness raising and behaviour changes relating to condom use. Because CT is asymptomatic in about 80% of cases, screening can also provide an effective method of early detection. In the US and Australia, sexual health guidelines recommend annual CT screening in primary care for all sexually active females aged between 15 and 25 years, and for sexually active young males in high risk groups or clinical settings (e.g. adolescent clinics, correctional facilities, STD clinics).6, 7, 8 However, only a limited number of countries have taken a systematic approach to effect Chlamydia control and only 13 of 29 countries in Europe have national guidelines for screening, diagnosis and management.9

Chlamydia trachomatis screening is non‐invasive and typically involves a urine test or swab for females, and a urine test for males. In Australia, CT screening most commonly occurs through opportunistic screening during a GP consultation. The 2007/2008 national GP CT testing rate per 100 sexually active individuals was 8.0%, although it was considerably higher in females (12.5%) compared with males (3.7%).10 In the US, significant improvements in the Chlamydia screening rates have been achieved through targeted programmes with effective rates of 45% for insured and 58% for Medicaid‐covered sexually active women aged 16–24 years.11 Whilst there are significant variations internationally in screening and surveillance programmes, what it clear is that screening rates remain lower in younger adults and at risk groups than the desired target rates.9, 10, 11, 12

Despite the availability of non‐invasive testing methods and highly effective medical treatments, rates of screening for STIs remain low in younger adults.10 Whilst screening in primary care settings may be improved by the universal offer of screening to some patients,13 Low et al.14 found that there was little evidence to support opportunistic CT screening across settings for young people aged less than 25 years. This creates an imperative to develop insight and evaluate the features of interventions that can more effectively promote CT screening and engage this younger demographic.

Previous sexual health research15 and current government sexual health policies in countries such as the UK16 have highlighted that gaining the consumer (or participant) perspective is central to understanding how to increase the utilization of sexual health screening programmes. This mirrors a wider recognition of the importance of consumer orientation in public health service delivery.16, 17 Social marketing is a strategic framework that has successfully utilized a consumer‐centred approach to support attitudinal and behaviour change at a group or community level across numerous health issues.18, 19 Therefore, it may have utility in facilitating access and use of Chlamydia screening among young people in the community.

This article presents the findings from a systematic literature review that examines current evidence regarding the nature and effectiveness of consumer approaches to promote opportunistic CT screening within a range of community settings to engage young people (<30 years). Whilst a recent review investigated home‐based Chlamydia and gonorrhoea screening strategies and outcomes,20 this study is the first to evaluate the approaches within a variety of ‘non‐clinical’ community settings. Furthermore, although current CT interventions use a variety of frameworks and approaches, social marketing has been suggested as a particularly relevant and promising approach to sexual health programmes. The present systematic review also assesses included interventions against recognized social marketing benchmark criteria.21 Whilst it is important to acknowledge that included interventions may not have been planned using the social marketing framework, this assessment can help identify strengths and weaknesses in current approaches and identify useful strategies for future interventions. This approach has been used in previous reviews on the effectiveness of behaviour change interventions for other health issues.19, 22

Social marketing is a systematic framework that uses marketing principles to promote socially beneficial behaviour change.23 It is distinctive from other approaches as it is consumer orientated and facilitates change by enhancing the benefits associated with the behaviour and minimizing the costs.23 Well‐designed social marketing programmes have been effective in promoting health behaviour change in relation to substance misuse, food and nutrition and physical activity;19, 22 and other screening behaviours, for example, colorectal cancer.24 Given the effectiveness of social marketing in other health behaviours, it is appropriate to investigate the utility of its principles to promote CT screening. Whilst the majority of interventions in the systematic review were not conceptualized according to social marketing principles, the social marketing benchmarking criteria provide insight into the relative strengths and weaknesses of existing interventions from this perspective. Furthermore, this allows for recommendations for the development of future CT screening that could utilize social marketing as a framework.

Method

A systematic literature search using the databases Medline, Web of Knowledge, PubMed, Scopus and the Cumulative Index to Nursing and Allied Health was conducted to identify published behavioural interventions to increase Chlamydia screening. The following terms were used to search for academic peer‐reviewed published articles published in English from January 2002 to June 2012: ‘Chlamydia AND (screen or screening or intervention* or social marketing or program* or campaign)’. Titles and abstracts were screened by two reviewers to identify potentially relevant articles. Reference lists of identified articles were also searched to identify any additional relevant papers. Full‐text articles were read independently by two of the authors to ensure consensus was reached on the final articles to be included. Studies were included if they measured CT screening behaviour (not just knowledge or beliefs), targeted CT screening only1, targeted people under 30 years of age and were implemented in non‐clinical settings. Whilst it is noted that national population screening rates are often provided for a more limited age range (15–24 years), many of the relevant research studies included people aged from 15 to 30 years and were included to ensure all relevant literature was reviewed.

Exclusion criteria were as follows: educational or awareness raising programmes with no behaviour change objectives, poster presentations and review articles, and non‐academic and unpublished grey literature. Whilst included studies may have also aimed to change knowledge or beliefs, the focus of this study was on reviewing interventions in relation to their effectiveness in promoting CT screening and follow‐up in at‐risk segments, and investigating the settings and strategies used. The three primary behavioural outcome measures reported included number of tests (as a proportion of those exposed to the intervention), positivity rate (as a proportion of those tested) and treatment rates were reported (as a proportion of those who tested positive). Behaviours such as ‘logging on to a website’ or ‘downloading’ information or forms were also noted if reported. Finally, consistent with the objectives of the systematic review, an overall consensus about the interventions was reached by two of the reviewers. All interventions were judged against three primary behavioural outcomes: the proportional screening rates, the number of positive tests and the ability of the intervention to support treatment in participants who tested positive (also reported as a proportional rate). Interventions included in the systematic review were also assessed against the UK National Social Marketing Centre's Social Marketing National Benchmark Criteria.16 The benchmark criteria present eight integrated elements that should be featured in a comprehensive social marketing intervention (see Table 1). Interventions were also evaluated for quality on the basis of study design and outcome measures using the GRADE protocol.25 Coders met periodically during the process, and intercoder reliability checks were conducted on the entire sample between the two researchers. The coefficient of agreement [the total number of agreements (n = 17) divided by the total number of coding decisions (n = 20)] was 85%, and a third researcher resolved any disagreements.

Table 1.

Outline of the social marketing national benchmark criteria (French, Blair‐Stevens, 2005)

Benchmark Description
Behaviour The intervention needs to have a clear focus on a specific behaviour (e.g. CT screening), not merely psychological factors such as attitudes or intentions. There needs to be a detailed understanding of the ‘problem’ and ‘desired’ behaviours.
Customer Orientation The intervention should be informed by a broad and robust understanding of the customer. Formative research and pre‐testing are important in identifying consumer characteristics and needs.
Theory Interventions should be informed by relevant behavioural theories that are used to understand the target behaviour (e.g. beliefs, barriers).
Insight Formative research should lead to an insight into the factors that influence behaviour (e.g. psychological and physical barriers). This insight is important for developing the intervention, and in particular addressing issues surrounding exchange and competition.
Exchange This involves understanding the benefits and costs to the individual of behaviour change and maintenance. In particular, there is a need for the intervention to maximize the benefits and minimize the costs to make the behaviour change attractive to the individual.
Competition This element recognizes that lots of different factors compete for the individual's time and attention; these can impede behaviour change. The intervention therefore needs to minimize the impact of competition, which could be achieved through maximizing the value of the exchange. Development of strategies that aim to minimize the potential impact of the competition.
Segmentation The target ‘audience’ is not homogeneous and may have different attitudes, beliefs and barriers which have the potential to influence intervention success. As a result, it is important to identify subpopulations (i.e. segments) that share similar geographic, psychological and behavioural characteristics. Interventions should be tailored according to the distinct characteristics of these segments.
Methods Mix This final element emphasizes the importance of using a range of different methods to promote behaviour change. That is, interventions cannot merely rely on education and also need to incorporate elements of the marketing mix (i.e. product, place, promotion and price).

Results

The search strategy yielded a total of 10 593 references (see Fig. 1). After excluding duplicates and papers not fulfilling the inclusion criteria, 30 full‐text articles were reviewed with a further seven studies identified from references list searches. Of these 37 articles, 17 papers in primary care or hospital settings were excluded. However, two programmes which offered a choice of clinic or community‐based screening were included.26, 27 A final total of 20 papers were included in the systematic review.

Figure 1.

Figure 1

Flowchart.

From the 20 papers, 18 interventions were reported on (two papers from Gaydos et al.28, 29 were both reporting results from the same intervention, and van Bergen et al.30 and van den Broek et al.31 were also two papers reporting on the same intervention). The interventions were conducted in the following settings: pharmacies,32, 33, 34, 35 high schools,36, 37 universities,38, 39 Internet‐based28, 29, 40 and media‐based campaigns.26, 27 However, these are difficult to strictly categorize as many interventions were conducted across settings. Intervention designs included one RCT,41 two quasi‐experimental studies,39, 42 two pre‐ and post (no control)‐evaluations designs31, 34, 43 and six cross‐sectional/post‐test designs.27, 32, 33, 38, 44, 45 The remaining eight interventions did not explicate study designs, but could be described as observational or descriptive designs.28, 29, 35, 36, 37, 40, 46, 47 Most targeted adolescents and young adults (14–29 years) although some only specified an adult target group, or no target group (as they were observational studies). Five had specific gender target groups, three females only28, 35, 36 and two males only.40, 45 Audiences were also targeted within particular settings or groups, for example. pharmacy customers,32, 33, 35 music festival attendees,44 high‐school students36, 37 and men who were members of a private health fund45 or those living within specific geographic regions. Three interventions targeted disadvantaged communities one multicultural neighbourhood,34 one disadvantaged school37 and one rural high school.36 Three interventions also targeted people performing other non‐STI‐related health behaviours, for example those attending a health clinic38 and young women buying oral contraceptives from a pharmacy (Table 2).34, 35

Table 2.

Summary of articles Chlamydia trachomatis (CT) screening interventions in community settings

Study Description Outcomes
Aldeen et al. (2010)
UK38
Target: University students Overall: Mixed results
CT tests: Urine(males), Vaginal swab (females) Outcomes measuresa
Number of tests: 88 (35.2%)
Positivity: 4.2%
Treatment: N/A
Setting: University clinic
Design: Cross‐sectional
Alicea‐Alvarez et al. (2011)
US36
Target: Adolescent females Overall: Mixed Results
Outcomes measures
Number of tests: 51/165 (30.9%)
Positivity: N/A
Treatment: N/A
CT tests: Urine test
Setting: High‐school clinic
Design: Cross‐sectional
Andersen et al. (2002)
Denmark41
Target: Males and females aged 21–23 years Overall: Mixed results
Outcome measures
Number of tests: 771 (38.6%) and 659 (33%)
Positivity: 42 (6.5%) and 42 (8%)
Treatment: N/A
CT tests: Home vaginal swab
Setting: Country region
Design: Randomized control trial
Anderson et al. (2011)
UK32
Target: Adults Overall: Positive effect
Outcome measures:
Number of tests: 14 378 (2 years)
Positivity: 1131/14 378 (0.8%)
Treatment: 533/1131 (47.1%)
CT tests: Home urine test
Setting: Pharmacy
Design: Cross‐sectional
Barry et al. (2008)
US37
Target: Adolescents (male and female) Overall: Mixed results
Outcomes measures
Number of tests: 537/967 (63%)
Positivity: 1.3% (identified at risk)
Treatment: N/A
CT tests: Urine test
Setting: High‐school clinic, disadvantaged area
Design: Cross‐sectional
Brabin et al. (2009)
UK35
Target: Females <25 years requesting contraception Overall: Mixed results
Outcome measures
Number of tests: 264/1348 (17.6%)
Positivity: 24/264 (9.1%)
Treatment: 22/24 (91.7%)
CT tests: Home Urine Test
Setting: Pharmacy
Design: Quasi‐experimental
Chai et al. (2010)
US40
Target: Males >14 Overall: Positive results
Outcomes measures
Number of tests: 512 (31%)
Positivity: 64/501 (13%)
Treatment: N/A
CT tests: Home urine test
Setting: Internet based
Design: Cross‐sectional
Chen et al. (2007)
Australia26
Target: 16–29 years Overall: Mixed results
Outcomes measures
Number of tests: 2842 (men) and 6049 (women) Not reported
Positivity: 1.9% (men) and 4.3% women
Treatment: N/A
CT tests: Existing services
Setting: Media campaign.
Design: Cross‐sectional
Emmerton et al. (2011)
Australia33
Target: Adults Overall: Mixed Results
Outcomes measures
Number of tests: 18/156 (12%)
Positivity: N/A
Treatment: N/A
CT Tests: Home urine test
Setting: Pharmacy
Design: Cross‐sectional
Gaydos et al. (2006, 2009)
US28, 29
Target: Females >14 years Overall: Positive effect
Outcomes measures
Number of tests: 1254b (32%) (Wave 1)
3774b (32.4%) (Wave 2)
Positivity: N/A
Treatment: N/A
CT Test: Home vaginal swab
Setting: Regional, Internet Campaign
Design: Cross‐sectional/Observational
Jones et al. (2007)
South Africa42
Target: Women – aged 14–25 years Overall: Positive effect
Outcomes measures
CT tests: Clinic 131b (42%); Home 143b (47%)
Positivity: 22%
Treatment: N/A
CT Test: Clinic or home vaginal swab
Setting (s): Mail and clinic
Design: Quasi‐experimental
Kwan et al. (2012)
Australia43
Target: Not specified Overall: Positive effect
Outcomes measures
CT Request form downloaded: 675
CT Tests: 378/675 (56%)
Positivity: 378b (18%)
Treatment: 50%b within 7 days
CT Tests: Urine test (males), vaginal swab (females)
Setting: Website
Online intervention to promote self‐risk assessment, testing and referral for treatment (n = 675)
Novak and Karlsson (2006)
Sweden47
Target: Not specified Overall: Low‐moderate results
Outcomes measures
19 518 website visits
CT Test Requests: 1405/256, 886 (0.4%)
CT Tests: 906/1405 (62.5%)
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Website
Design: Cross‐sectional
Oh et al. (2002)
US46
Target: Males and Females 15–25 years Overall: Low‐moderate results
Outcomes measures
Hotline use: 642 calls
(Average 99 calls/week vs. 9 calls per week pre‐campaign)
CT tests: 31/642 callers (4.8%)
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Media Campaign
Design: Cross‐sectional
Sacks‐Davis et al. (2010)
Australia44
Target: males and females aged 16–29 years Overall: Low‐moderate results
Outcomes measures
Number of tests: 67/313 (21%)
Positivity: 1/67 (1%)
Treatment: N/A
CT Test: Home‐Urine Test (males); Home – vaginal swab (females)
Setting: Music festival
Design: Cross sectional study
Scholes et al. (2007)
US45
Target: Men Overall: Low results
Outcomes measures
CT Tests: 5.7%
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Health fund members
Design: RCT
van Bergen et al. (2004)
Netherlands40
Target: Females (15–29 years) collecting contraceptives Overall: Moderate results
Outcomes measures
Number of tests: 73/270 (27%)
Positivity: 4.2%
Treatment: N/A
CT Test: Home Urine Test
Setting: Pharmacy, Low income area
Design: Cross‐sectional
Vaughan et al. (2010)
Ireland39
Target: 18–29 years Overall: Positive effect
Outcomes measures
Number of tests: 592/1249 (47.5%)
Positivity: 21/358 (3.9%)
Treatment: 18/21 (87%)
CT Test: Clinic Urine Test
Setting: University
Design: Quasi‐experimental
van Bergen et al. (2010)c, 30
van den Broek et al. (2010)
Netherlandsc, 31
Target: 16–29 Overall: Low results
Outcomes measures
CT Tests: 73/270 (27%)
Positivity: 4.2%
Treatment: N/A
CT Test: Home‐Urine Test (males); Home – vaginal swab (females)
Setting: Website
Design: Cross‐sectional
Wilkins and Mak (2007)
Australia27
Target: 15–24 years Overall: Moderate – positive effect
Outcomes measures:
CT Tests: females (21%b); males (29%b)
Positivity: Females (12%b); males (4%b)
Treatment: N/A
Clinic urine test (males), clinic vaginal swab (females)
Setting: Media
Design: Cross‐sectional
a

Studies may have also reported changes in knowledge or attitudes etc; however, only behavioural outcomes are reported.

b

Only percentages reported.

c

For interventions with more than one publication, the most recent results are reported.

Effectiveness of interventions on screening, positivity rates and treatment rates

In relation to uptake of CT screening, nine were judged as having a high impact,28, 29, 32, 36, 37, 38, 39, 40, 41, 42 three a moderate impact27, 34, 35, 44 and five a low impact on screening rates.30, 31, 33, 45, 46, 47 Three of the four interventions that achieved a higher positivity rate included a formal risk assessment for participants as part of their strategy to promote testing in higher risk groups.27, 40, 43 None of the interventions with lower rates of positive tests included such a formal risk assessment.

Of the 11 interventions where participants had a positive test result, only four reported the number of those who accessed treatment.32, 35, 39, 43 This ranged from 47.1 to 91% of those who had tested positive for Chlamydia following participation in the intervention.

Social marketing benchmark criteria

Each of the included interventions was evaluated against the social marketing benchmark criteria (see Table 3). Of the nine interventions found to have a positive impact, two36, 39 met seven of the eight social marketing benchmark criteria, but did not report the theory utilized, and one met six criteria, but did not report the use of theory or segmentation.29 Another intervention met five benchmark criteria omitting customer orientation, theory and competition,43 one met five criteria but did not report against customer orientation, theory or insight,37 one met five criteria but did not report against theory, insight or exchange38 and one met five criteria: but did report use of theory, competition and segmentation.32 Finally, one intervention met four of the eight benchmarks, whilst not reporting against theory, insight, exchange and segmentation.40

Table 3.

Community base Chlamydia trachomatis (CT) interventions evaluated utilizing social marketing benchmark criteria

Study Coding against benchmark criteria
Aldeen et al. (2010)
UK38
  1. Target behaviour: Clinic urine test (males), clinic vaginal swab (females)

  2. Customer Orientation: Literature search conducted on CT screening studies.

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: N/A

  6. Competition: Addressed barriers of access to screening by utilizing an alternative setting

  7. Segmentation: 18 + , sexually active, attendees of university health centre.

  8. Methods Mix: Promotion –posters, flyers, information sheets; Place – convenience and accessibility.

Alicea‐Alvarez et al. (2011)
US36
  1. Target behaviour: Clinic urine test

  2. Customer Orientation: Literature review of similar CT screening programmes in high schools.

  3. Theory: N/A

  4. Insight: Analysis and review of literature to support intervention and understand barriers and motivators

  5. Exchange: Gift voucher incentives.

  6. Competition: Soft drinks and water provided to aid participants to give a sample. Students excused from classes to provide samples, screening process designed to maximize confidentiality and privacy.

  7. Segmentation: Materials designed for adolescent girls in rural setting

  8. Methods Mix: Promotion – education including PowerPoint presentation delivered by research team to students in class, Q&A session, incentives; Place – convenience

Anderson et al. (2002)
Denmark41
  1. Target behaviour: Home vaginal swab

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: 6. Competition:

  6. Segmentation: N/A

  7. Methods Mix: Leaflets, home sampling kit.

Anderson et al. (2011)
UK32
  1. Target behaviour: Home urine test

  2. Customer Orientation: Informed by pilot intervention data

  3. Theory: N/A

  4. Insight: From pilot data – understanding issues of access; male utilization of this mode of testing

  5. Exchange: Offering benefit (finding out if positive) by reducing costs (i.e. barriers) to testing

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Trained pharmacist consultations, email/text/phone results service, information booklets.

Barry et al. (2008)
US37
  1. Target behaviour: Clinic urine test

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: Prizes (from $10‐$80) issued randomly, treatment services offered at times and locations convenient to students.

  6. Competition: Addressed barriers of access, confidentiality, privacy

  7. Segmentation: Non‐sexually active students were discouraged from testing.

  8. Methods Mix: Promotion – education: 10 minute presentation on CT and screening, incentives; Place – convenience: Price – parents not informed of the results. Steering committee (nurses, teachers, students, parents) for intervention. STD factsheets.

Brabin et al. (2009)
UK35
  1. Target behaviour: Home urine test

  2. Customer Orientation: Informed by pilot intervention data

  3. Theory: N/A

  4. Insight: From pilot data – understanding of whether screening was acceptable to pharmacies

  5. Exchange: Offering benefit (finding out if positive) by reducing costs (i.e. barriers) to testing

  6. Competition: Addressed barriers of access, cost and convenience.

  7. Segmentation: Females >25 requesting Emergency Hormonal Contraception at pharmacies

  8. Methods Mix: Trained pharmacist consultation, home kit and free postage, fact sheet, information on local treatment services

Chai et al. (2010)
US40
  1. Target behaviour: Visit website and home urine test

  2. Customer Orientation: Some scoping of literature – identified lack of research in internet based interventions targeting men

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: N/A

  6. Competition: Address barriers of access to screening such as transport, cost, no health insurance, confidentiality

  7. Segmentation:

  8. Methods Mix: Free kits, testing and treatment, information booklet, flyers, radio, campaign website: www.iwantthekit.org. sampling kit.

Chen et al. (2007)
Australia26
  1. Target behaviour: CT test using existing services

  2. Customer Orientation: Formative – focus groups, pre‐testing of campaign messages. Qualitative evaluation via intercept + survey

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: N/A

  6. Competition: N/A

  7. Segmentation: Gender specific messages

  8. Methods Mix: Promotion – Print Ads, Take‐Away Cards in bars, clubs, hotels and tertiary institutions, newspapers, magazines, local press, transport, website.

Emmerton et al. (2011)
Australia33
  1. Target behaviour: Home urine test

  2. Customer Orientation: Interviews with pharmacy staff.

  3. Theory: N/A

  4. Insight: Commitment issues relating to workload, issues with staff member taking responsibility for driving the distribution of specimen collection kits, staff discomfort at verbally introducing the screening concept.

  5. Exchange: N/A

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Trained pharmacy staff, Self‐collection postal kit, text/phone results service, in‐store posters and leaflets.

Gaydos et al. (2006, 2009)
US28, 29
  1. Target behaviour: Visit website and home vaginal swab

  2. Customer Orientation: Formative – focus groups to inform internet delivery. Quantitative results from those who sent kit in (via survey) and those who didn't.

  3. Theory: N/A

  4. Insight: Address barriers to access and screening such as fear of pelvic exam, embarrassment, cost, parental involvement/privacy and stigma. Understanding of women and the internet for getting info on STDs.

  5. Exchange: Encouraged women to adopt behaviour (CT testing) by offering benefit (test result) and reducing barriers (collection of urine in own home)

  6. Competition: Address internal (fear of pelvic exam, embarrassment) and external (time to visit clinic, costs, parental involvement) competition by providing alternatives to access (home based kit) and screening test (self test).

  7. Segmentation: N/A

  8. Methods Mix: Promotion – flyers, radio, newspapers, magazines, website: iwantthekit.org

Jones et al. (2007)
South Africa42
  1. Target behaviour: Clinic or home vaginal swab

  2. Customer Orientation: Interviews conducted with participants on enrolment regarding their socio‐demographic characteristics and their sexual history. Interviews were conducted with participants post intervention on the feasibility and acceptability of the intervention.

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: Free screening equipment, educational materials and treatment services in exchange for performing screening tests.

  6. Competition: Educational materials and provision of free testing kits, and free screening and treatment services attempted to overcome financial barriers to CT screening among a poor population.

  7. Segmentation: All participants were interviewed at enrolment on socio‐demographic and sexual history.

  8. Methods Mix: General information sessions on STs and study description sessions held at four community based youth groups and two public health clinics. Home kits contained instruction booklet, educational materials testing kit (product), and a toll‐free phone‐line number. Women in the clinic received a bag containing condoms, educational materials and a clinic appointment card.

Kwan et al. (2012)
Australia43
  1. Target behaviours: Urine test (males), vaginal swab (females)

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: Barriers to testing in young people – costs, clinic waiting times, inconvenience, fear of medical procedure, stigma, and lack of privacy. Also no routine testing by GPs (especially men and young people in rural areas). Low uptake of home tests – fear? Suspicion? embarrassment

  5. Exchange: Home based tests overcome some barriers

  6. Competition: N/A

  7. Segmentation: Community

  8. Methods Mix: “Get the facts’ Website – Online risk self‐assessment, Mass media (print, radio, convenience ads in pubs, clubs, cafes and unis); Printout referral to Path West Labs; Advice about the test and what will happen, and that it is covered by Medicare; Promotion of the Testing services and locations (Path West Labs – >70 throughout WA); advice service for those <16 years); choice to attend DOHA funded Sexual Health service or a medical practitioner for treatment

Novak and Karlsson (2005)
Sweden47
  1. Target behaviour (s): Log on to website; order home urine test; Test; Use test; return test; log on to check results; visit physician if possible; participate in counselling if offered (social work); consent to partner tracing

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: Home sampling is easy – but many kits are never used (even when provided and posted free). Need to include men and women in promotion to effective reduce screening rates

  5. Exchange: Secure website; free kits; easy access to results; only need to present to physician if positive result; print out of referral to take to physician; offered counselling and partner tracing if positive by a trained social worker (support)

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Provision of home testing kit (Mail out);
    • Related Chlamydia Website (secure online reporting; interpretation of results; print out of physical referral if test was positive; printed referral from website for positive results;
    • provision of counselling (social work) intervention on basis of physician letter to indicate treatment had been sought;
    • reminder emails and phone calls if no letter feedback from physician to indicate treatment had been access within 4 weeks (if results +ve) message only if test was negative
    • Marketing strategy (press conference; posters at youth centres and schools; banner ad on popular ‘chat’ website; video commercial at local sporting arena
Oh et al. (2002)
US46
  1. Target behaviour: Call CT hotline or Options Phone Line; home urine test

  2. Customer Orientation: Pre – formative campaign and focus groups to develop intervention. Pilot tested materials prior to intervention. During – quantitative data;

  3. Theory: Theory of Reasoned Action & Media Practice Model

  4. Insight: Identify and address barriers – e.g. correct misinformation about CT, privacy issues, access. Motivators (use of TV as source of information for adolescents) sense of self and lived experience

  5. Exchange: Hard talk about STIs so get the facts from the phone line/brochure; serious consequences if not treated (and asymptomatic); important to call; offer of 5 testing sites in local area

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Mail out (brochure); TV and radio campaign; Pre‐recorded Check‐it‐Out Chlamydia Hotline; A staffed Chlamydia Options information line; a free Chlamydia test (LCR) (clinic‐based);

Sacks‐Davis et al. (2010)
Australia44
  1. Target behaviour: Home urine test (males), home vaginal swab (females)

  2. Customer Orientation: Cross‐Sectional Survey. Process and Impact Evaluation

  3. Theory: Note HBM but unclear if utilized in design of study

  4. Insight: Address barrier of access, ease of testing. Tried to understand cliental using this venue for intervention.

  5. Exchange: Incentives were offered to participate (cold drinks, lollipops, prize draw for MP3 player and CD vouchers).

  6. Competition: N/A

  7. Segmentation: Targeted young people aged 18–29 who attended a music festival and are statistically more likely to be sexually active and at risk of STDs.

  8. Methods Mix: Market stall in festival site, staff on site to recruit participants, use of incentives (cold drinks, lollipops, prize draw for MP3 player and CD vouchers).

Scholes et al. (2007)
US45
  1. Target behaviour: Home urine test

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: Young men don't often attend health care settings and need for interventions to target male to lower infection (not customer need though)

  5. Exchange: Offering benefit (finding out if positive) and reducing costs to testing; address barriers via mail out strategy – time, logistics, discomfort

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Letter + test request form; Letter + mail back kit)

van Bergen et al. (2004)
Netherlands34
  1. Target behaviour: Home urine test

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: N/A

  6. Competition: N/A

  7. Segmentation: low income females <30 years old and using contraceptives

  8. Methods Mix: Information leaflet, and a screening kit

Vaughan et al. (2010)
Ireland30
  1. Target behaviour: Clinic urine test

  2. Customer Orientation: Literature review to identify issues and barriers to screening. Process evaluation (seven [six female, one male] participant interviews conducted post intervention).

  3. Theory: N/A

  4. Insight: Identified that young people desired a hassle free, non‐clinical setting screening process.

  5. Exchange: Provided participants with a free, anonymous, easy to access, and private screening process. Volunteers offered €25 vouchers as incentives. Offered participants a sense of relief and peace of mind by taking a test.

  6. Competition: Addressed barrier of screening in clinical settings by offering an alternative non clinical setting. Increased self‐efficacy for testing by reducing embarrassment for taking a test by creating a normalized – everyone is doing it, atmosphere.

  7. Segmentation: Specifically targeted students aged 18–29 who are most at risk of CT.

  8. Methods Mix: Programme was part of an overall Sexual Health & Awareness & Guidance (SHAG) Week. Posters and leaflets distributed around campus. Media releases, radio broadcasts, email alerts and newspaper articles publicises the intervention. Intervention steering group (student health units and student unions). Use of peer volunteers. Testing packs distributed around campus, especially in male and female toilets.

van Bergen et al. (2010)30
van den Broek et al. (2010)
Netherlands31
  1. Target behaviour: Home urine test (males), home vaginal swab (females)

  2. Customer Orientation: formative research and pilot data
    • Insight: identified and addressed barriers
  3. Theory: N/A

  4. Insight: N/A

  5. Exchange: used home based test to reduce barriers

  6. Competition: N/A

  7. Segmentation: N/A

  8. Methods Mix: Invitation letter (population register – invited to participate if are or have been sexually active) promoting the website and a personal code; Secure Website (information; ‘risk assessment score’; place to request home sampling kit; facility to notify partners anonymously; Home Chlamydia test (urine or vaginal swab); Testing in three regional accredited laboratories; Advice and referral letter for treatment (self and current partner); Positive test recipient receive a test package 6 months after first test
    • Repeated invitation letter (1 year) – no results available yet on value of repeat invitations
Wilkins and Mak (2007)
Australia27
  1. Target behaviour: Clinic urine test (males), clinic vaginal swab (females)

  2. Customer Orientation: N/A

  3. Theory: N/A

  4. Insight: Focus groups – not described

  5. Exchange: use of reminders to overcome barriers

  6. Competition: N/A

  7. Segmentation: GPs and community

  8. Methods Mix: Mass and narrow case media (TV, radio, posters (pubs/clubs hotels/uni/tafe/ magazines and print ads)– directing people to Interactive website (Q&A); SMS (to people registered to receive smoking SMS/for this project); GPs – Chlamydia Information Kits; Posters for waiting rooms

Of the interventions that had low‐modest impact, one met seven criteria but did not report use of theory,35 one met six criteria but did not report the use of theory or competition44 and one met six criteria but not competition and segmentation.46 Two of these interventions met four criteria but did not report customer orientation, theory, competition or segmentation,45, 47 and another met four criteria but did not feature the use of theory, insight, competition or segmentation.30

Behaviour

All 20 interventions had a specific behaviour goal of increasing participation in Chlamydia screening. Four interventions promoted opportunistic on‐site CT testing in clinics, in educational settings, in two universities38, 39 and in two high schools.36, 37 Another intervention randomized participants to on‐site testing at a youth centre or community health centre as part of a clinical trial42. All of these interventions promoted urine CT tests, except Aldeen et al.38 who offered a vaginal swab. Two interventions promoted screening at community health clinics and/or with a GP.26, 27

Fourteen interventions promoted home CT screening behaviours, via purchased32 or free CT kits from community pharmacies,33, 34, 35 at a music festival,44 a youth centre participating in a clinical trial,42 direct mail to participants41, 45 or online.28, 29, 30, 31, 40, 46, 47 Fifteen interventions promoted the use of urine CT tests kits. Three promoted use of vaginal swabs,28, 29, 41, 42 while one43 provided urine tests for men and vaginal swab tests for women. Only one intervention (reported in two papers) provided users a choice of vaginal or urine testing.30, 31

Customer orientation

Only eight interventions reported the conduct of primary formative research with the target audience prior to design and implementation. This included the use of interviews,33 surveys,44 focus groups,26, 28, 29, 46 pre‐testing of campaign messages26, 46 and the conduct of pilot interventions.30, 31, 32, 35, 46 Three others interventions demonstrated limited customer orientation during and after the intervention via the conduct of process and audience impact evaluation.26, 39, 42, 44, 46 Only one study reported on data collected from those who both participated in screening and those who did not.28, 29 The remaining interventions reported very limited customer orientation via their reference to secondary sources to inform design.36, 37, 38, 40

Theory

According to this benchmark, interventions should be informed by relevant behavioural theories that are used to understand the target behaviour. Only two included interventions identified the use of theory. Sacks‐Davis et al.44 referred to the Health Belief Model and Oh et al.46 to the Theory of Reasoned Action and the Media Practice Model as theoretical frameworks. However, neither explicitly stated how these theories were applied to the design, conduct or evaluation of the interventions.

Insight

Those interventions that conducted formative research highlighted the following insights into their target audiences: difficulty accessing issues to medical settings and the appeal testing in non‐medical environments,32, 39 the attitudes of clientele attending music festivals44 and barriers to staff delivering CT screening in the pharmacy setting.33

Other interventions referenced only existing research to provide insight into target audience barriers and motivators to undertaking the CT screening. For example, barriers to testing in young people, such as costs, clinic waiting times, inconvenience, fear of medical procedure, stigma, and lack of privacy, stigma, embarrassment and a lack of routine testing by GPs27, 28, 29 and the need to correct misinformation about CT.46 Motivators for seeking CT testing such as exposure of adolescents to information on CT and a young person's sense of self and lived experience were also identified in a single study.46

Exchange

All of the reviewed studies sought to minimize costs associated with behaviour change to make it more attractive to the individual. All except one32 addressed the monetary cost involved in screening by providing free tests/kits. Mitigating other costs (e.g. time, effort) was addressed more comprehensively in some interventions than others. For example, to promote the uptake of home CT screening behaviours, some interventions distributed kits directly by mail to participants,41, 45 while others necessitated time and effort to request a kit via a mailed form45 or online requests28, 29, 30, 40, 46, 47 or provided tests in more accessible locations.32

Interventions also addressed barriers to specimen delivery to a laboratory by mail32, 33, 34 or by onsite processing.37 Access barriers to receiving results were addressed by sending results via use of phone, SMS, email or post and access to treatment also by post44. Other barriers of access addressed included transport, health insurance and confidentiality.40 It is also likely that many of these home‐based interventions also overcame some of the embarrassment or stigma associated with asking for and receiving a CT test – although this was not reported against in any of the studies.

In terms of offering incentives or benefits, most interventions highlight the benefits of screening and treatment, for example a sense of relief and peace of mind by taking a test.39 Others interventions offered, prizes (from $10‐$80) issued randomly and treatment services offered at times and locations convenient to students,37 cold drinks, lollipops, a prize draw for MP3 player, CD vouchers,44 access to free, anonymous, easy to access and private screening process,39 soft drink, water and class leave passes36 and volunteers offered monetary vouchers as incentives.36, 39

Competition

All of the interventions sought to enhance the exchange for the target audience by addressing the barriers of access to screening in the primary care setting by utilizing non‐clinical settings (e.g. music festivals or pharmacies), or via establishing a presence in an online environment. For example, use of home‐based kits addressed both internal barriers (e.g. fear of pelvic examination, embarrassment) and external barriers (time to visit clinic, costs, parental involvement).28, 29 Alicea‐Alvarez et al.36 directly addressed the competing behaviour of ‘attending class’ by offering ‘passes’ to attend the school clinic. Wilkins and Mak27 also used reminders in recognition that participants’ may be distracted or forget about screening.

Segmentation

With the exception of four interventions, two of which were set in pharmacies,27, 32, 33, 43, 47 all interventions defined specific target audiences for their programme. Eight were defined on the basis of age,26, 27, 30, 37, 41, 44, 46 one on gender,45 four on age and gender29, 34, 35, 36, 40 and one targeting attendees at a University.38 Geographic segments were also targeted including schools within disadvantaged or rural communities in two interventions,36, 37, 39 at a regional level41 and another at a state level.26 Finally, one intervention targeted attendees at a music festival.44 Whilst tailoring of the programmes to meet the specific needs of these segments may have occurred in the design of the programmes. Unfortunately, if or how this was done was not made explicit within the reporting of most of the articles. Three exceptions included Alicea‐Alvarez et al.36 who discussed the development of gender‐specific messages and materials for adolescent girls in a rural setting, and two other interventions, which reported tailoring resources for GPs and community.26, 27

Methods mix

Social marketing interventions do not rely solely on education, but utilize the breadth of the marketing mix: product, price, place and promotion.

Product

‘Product’ refers to the desired behaviour (actual product) and the set of benefits associated with the desired behaviour (core product).18 In this study, the use of a CT screening test is the desired behaviour (actual product), whilst the benefits that people accrue from screening use such as confidential free treatment, avoiding infertility caused by Chlamydia, or not infecting future partners are core products. The mostly commonly promoted actual product was home‐based urine test kit,32, 35, 40, 43, 44, 47 and urine tests which could be taken in ‘alternative’ settings.36, 37, 39, 42 Vaginal swabs were less frequently promoted both for home use28, 29, 41, 42, 43 and in one alternative on‐campus setting.38 Only one intervention provided users a choice or vaginal or urine testing.30, 31 Two interventions also promoted screening at community health clinics and/or with a GP, but did not specify the type of test.26, 27

Augmented products are the features that encourage uptake of an actual product or service. In this case, augmented products are those that support people in their use of the promoted CT screening test. In the interventions products used to support the use CT testing included interactive websites, phone information lines, information resources (on screen and printable), referral support (print outs or phone support) and partner notification services (online).

Supportive online features included facilities to assist participants to calculate risk scores, ‘Question and Answer’ educational information, results notification services45, 47 and an email facility for anonymous partner notification.30, 31 Phone services offered with some interventions included a recorded information line, staff supported information lines,32 counselling services and results notification services.32, 33, 39, 40, 44 These services offered information (and/or support) at various points including prior to screening, to communicate results and to support access to treatment or discuss results. Interventions in alternative non‐medical clinics within educational settings may have also provided trained personnel as an augmented service to support the uptake of screening in the target audiences,36, 37, 38, 39 although this was not clearly described.

Price

Price was addressed within the interventions in the following ways: the provision of a free test kit, or free treatment (addressing monetary costs), and providing testing in a non‐clinical home or educational setting; the use of direct mail for distribution of tests kits, online, phone or post results notification, phone information, support and advice lines; post‐treatment support including partner notification services (all addressing psychological and time costs).

Place

In regards to the ‘where’ of CT service use, the ‘actual product’ section of this paper has detailed how the ‘where’ component of screening (home based vs. clinic based screening) can influence uptake of screening behaviours.

Communication channels

The interventions used a variety of strategies including brochures, leaflets, posters and cards in 14 interventions.26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 37, 40, 41, 45, 46 Four of these distributed promotions via direct mail,30, 31, 41, 45, 46 seven via mass or narrow cast media (e.g. radio, TV, email alerts and video ads at sporting grounds).26, 27, 28, 29, 39, 40, 46, 47 In‐class presentations were also utilized in high‐school settings36, 37 and at youth groups and public health clinics.42 Websites were utilized in eight interventions,27, 28, 29, 30, 31, 40, 42, 43, 47 interpersonal channels in pharmacy settings32, 33 and at the music festival.44

Promotion

Not all the interventions specified promotional messages that were utilized as part of their programme. Of those with associated websites mentioned in publications describing included interventions, the following messages were identified. Firstly, “I want the kit’40 focusing on how participants could obtain free Chlamydia testing. Another, “Most people don't have a clue” focused on lack of knowledge about Chlamydia.27 This intervention also used rotating comic book style images with slogans including “Could my partner have it?’, ‘Could I be infertile?’, ‘My package looks good but could I have it?’ and ‘Could I have it again?’ to engage people at risk but potentially unaware. This intervention also used radio buttons highlighting where to get Chlamydia information and especially ‘Free testing’.

The ‘Get the Facts’ Website43 focused on information including signs and symptoms, risk factors and the need to get tested and treated. Vaughan et al.,39 also promoted Chlamydia screening during the Annual Sexual Health and Awareness and Guidance (SHAG) Week. However, no specific Chlamydia campaign materials could be identified via the website.

Discussion

To our knowledge, this is the first systematic review of community‐based Chlamydia screening interventions in a range of non‐clinical settings, and the first to utilize the social marketing benchmark criteria as a framework to evaluate the nature, strategies and outcomes of interventions against behavioural goals. This systematic review identified 20 articles examining the effectiveness of interventions to engage young adults in community‐based (non‐medical) settings to participate in CT screening. Whilst the overall quality of evidence available was low (including variations in study design, numbers of participants and a variation in the methods utilized to collect evaluation data), a descriptive systematic review of current approaches to promoting screening behaviours in community settings remains useful, generating lessons to be drawn to inform future research and intervention designs.

Overall, the results in regard to the potential effectiveness of community‐based interventions to promote CT screening in young people are promising. Across all of the interventions, 15 reported achieving high proportional screening rates26, 27, 29, 30, 32, 34, 41, 42, 44 when compared to rates within primary care settings in countries such as Australia. This suggests that screening promoted in community‐based settings may overcome some of the barriers to screening performed in health and medical clinics. All interventions that offered an alternative ‘clinic’ in educational settings resulted in higher rates of screening than is typical in the primary care setting, whilst those promoting home‐based tests produced mixed results with some higher and some lower rates than primary care. This suggests there may still be value to the target audience in face‐to‐face, supported screening and that overcoming some of the time, access and psychological barriers of traditional medical clinics may be effective in increasing participation in screening.

Four interventions also achieved a higher positivity rate than is currently observed in sexual health clinics.48 Three of these four interventions included a formal risk assessment for participants as part of the strategy to promote testing in higher risk groups,27, 40, 43 suggesting that the incorporation of such a programme feature may be important to reach higher risk segments of the population.

In relation to promoting screening that leads to treatment of Chlamydia, only four included interventions reported the proportion of those who accessed treatment following a positive test result (ranging between 47.1 and 91%).32, 35, 39, 43 Therefore, the effectiveness of community‐based screening as a pathway to treatment is less certain. This is important because an analysis of the intervention strategies shows a tendency of community interventions to only address the ‘cost’ of screening by focusing on improving access to ‘a kit’ and also to results. However, the barriers (time and psychological) that exist for young people to presenting to a medical clinic for treatment remain and were addressed in only one of the interventions, which also provided treatment by post.

Overall, the systematic review suggests that those programmes in a community setting that incorporated a greater range of strategies consistent with social marketing principles were likely to achieve more positive results (even if they were not planned with, or self‐identified as using the social marketing framework). This demonstrates the utility and potential of social marketing in the development of community‐based CT interventions. Furthermore, the social marketing benchmark criteria present a useful evaluation tool.

The systematic review also identified that interventions did not comprehensively utilize social marketing as a strategic framework. This is not surprising given that most included interventions were not self‐identified as social marketing. Given its effectiveness as a behaviour change approach, the analysis presented here generates useful insight that can inform the development and implementation of future CT screening interventions. A key finding was that included interventions often failed to use or failed to report use of formative research. Therefore, CT screening interventions should place a greater emphasis on formative research to understand the attitudinal and behavioural segments within the target audience. This should improve insight and opportunities for segmenting and tailoring interventions. Segmentation of the target audiences in the majority of the interventions was defined on the basis of age (range 14–29) and geographic region; only five specified a gender target group. Whilst tailoring of the programmes to meet the specific needs of these segmentation may have occurred in the design of the programmes – unfortunately, how this was done was not made explicit within the reporting of included studies. There was also no evidence of targeting of interventions to minority ethnic groups or other more vulnerable populations other than on the basis of geographic region.36, 37 Given the known differences in attitudes, stigma and health behaviours between genders and cultures, this is surprising, highlighting the need for consideration of programmes targeted and towards these market segments. Interestingly, two interventions also targeted on the basis of other behaviours (e.g. attendance at a University health clinic and purchase of oral contraceptives). Results from these two studies were both mixed, suggesting the need for further research to explore the value of ‘coupling’ CT screening with other behaviours.

Few existing CT screening interventions currently reported using behavioural theory in their design and implementation. Given the efficacy of use of theory to inform behaviour change programmes in other domains, future CT screening interventions should be theoretically framed. Post‐intervention process analysis of ‘why’ people did or did not participate would also offer insight.

Further research on young people from culturally and linguistically diverse also appears warranted. Finally, few current interventions adequately address the competition to the desired behaviour. Research to identify why a particular target segments do not present for screening and helping to identify competitive behaviours and influences should be a component of future CT screening programmes.

Conclusion

Whilst the quality of evidence remains low for current approaches, a systematic review of community‐based interventions to promote CT screening in young people <30 years suggests the potential utility of strategic community‐based social marketing interventions across a range of settings to promote screening at higher rates than currently exist in primary care for this target group. The use of clinics in educational settings (which overcome the barriers of time and cost of visiting a medical clinic) suggests the value of face‐to‐face support and interaction for some young people. The use of risk assessment tools also shows promise in community settings to increase positivity rates. Evaluation of programme strategies according to social marketing benchmark criteria highlighted that whilst few comprehensively incorporated all social marketing principles those that did incorporate, a greater range of strategies were likely to be effective. Given its effectiveness as a strategic approach to promote health behaviour change, the use of social marketing to develop future CT screening interventions holds potential to improve outcomes. Formative research to increase insight, facilitate engagement and enable segmentation and tailoring of screening interventions may also improve outcomes. Finally, robust evaluation is required to provide evidence of the efficacy of CT social marketing interventions and generate further insight on effective strategies for engaging young people.

Conflict of interest

None.

Funding

This work was supported by a small grant from the HIV/AIDS Related Programs Unit (HARP) (Illawarra Shoalhaven Local Health District) to assess the approaches and effectiveness of published behavioural interventions for Chlamydia screening.

Acknowledgements

Nil.

Correction added on 10 February 2015, after first publication: Ross Gordon's affiliation should read as Senior Lecturer, Marketing and Managements, Macquarie University, Sydney, NSW, Australia

Note

1

Interventions targeting Chlamydia in addition to other health issues were excluded, as Chlamydia is largely asymptomatic and therefore the focus of interventions is distinct.

References

  • 1. Australian Institute of Health and Welfare (AIHW) . Australia's Health 2012. Australia's health series no.13. Cat. no. AUS 156. Canberra, ACT: AIHW, 2012. [Google Scholar]
  • 2. Eurosurveillance . Genital chlamydia now the most commonly diagnosed sexually transmitted infection in England, Wales, and Northern Ireland. Euro Surveillance 2002;6:pii=1863. [Google Scholar]
  • 3. Low N; SCREen project team . Publication of report on chlamydia control activities in Europe. Euro Surveillance, 2008; 13: 18924. [PubMed] [Google Scholar]
  • 4. Peipert JF. Genital chlamydial infections. New England Journal of Medicine, 2003; 349: 2424–2430. [DOI] [PubMed] [Google Scholar]
  • 5. Australian Government Department of Health . Second National Sexually Transmissible Infection Strategy: 2010‐2013. Canberra, ACT: Australian Government Department of Health and Ageing, 2010. [Google Scholar]
  • 6. Workowski KA. Sexually transmitted infections and HIV: diagnosis and treatment. Topics in Antiviral Medicine, 2012; 20: 11–16. [PMC free article] [PubMed] [Google Scholar]
  • 7. U.S Preventative Services Task Force . Screening for chlamydial infection: recommendation statement. Annals of Internal Medicine, 2007; 147: 128–134. [DOI] [PubMed] [Google Scholar]
  • 8. Taskforce RRB . Guidelines for Preventive Activities in General Practice. South Melbourne, Vic: Taskforce RRB, 2009. [Google Scholar]
  • 9. European Centre for Disease Prevention and Control (ECDC) . Chlamydia Control in Europe. Stockholm: ECDC, 2009. [Google Scholar]
  • 10. Kong FYS, Guy RJ, Hocking JS et al Australian general practitioner chlamydia testing rates among young people. Medical Journal of Australia, 2011; 194: 249–252. [DOI] [PubMed] [Google Scholar]
  • 11. Centers for Disease Control (CDC) . 2012 Sexually Transmitted Diseases Surveillance. Available at: http://www.cdc.gov/std/stats12/ [Google Scholar]
  • 12. European Centre for Disease Prevention and Control (ECDC) . Review of Chlamydia Control Activities in EU Countries. Stockholm: ECDC, 2008. [Google Scholar]
  • 13. Guy RJ, Ali H, Liu B et al Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review. BMC Infectious Diseases, 2011; 11: 211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. International Journal of Epidemiology, 2009; 38: 435–448. [DOI] [PubMed] [Google Scholar]
  • 15. Wackett J. A theory‐based initiative to reduce the rates of chlamydia trachomatis infection among young adults in the Yukon. The Canadian Journal of Human Sexuality, 1998; 7: 347–356. [Google Scholar]
  • 16. Welsh Government . Sexual Health and Wellbeing Action Plan for Wales, 2010‐2015. Cardiff, Wales: Welsh Assembly Government, 2010. [Google Scholar]
  • 17. Donovan R. The role for marketing in public health change programs. Australian Review of Public Affairs, 2011; 10: 23–40. [Google Scholar]
  • 18. Kotler P, Roberto N, Lee N. Social Marketing: Improving the Quality of Life, 2nd edn Thousand Oaks, CA: Sage Publications, 2002. [Google Scholar]
  • 19. Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social marketing interventions for health improvements: what's the evidence? Public Health, 2006; 120: 1133–1139. [DOI] [PubMed] [Google Scholar]
  • 20. Jamil MS, Guy RJ, Hocking JS et al Home‐based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health, 2013; 13: 189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. French J, Blair Stevens C. Social Marketing Pocket Guide, 1st edn London: National Social Marketing Centre, 2005. [Google Scholar]
  • 22. Stead M, Gordon R, Angus K, McDermott L. A systematic review of social marketing effectiveness. Health Education, 2007; 107: 126–191. [Google Scholar]
  • 23. Grier L, Bryant CA. Social marketing in public health. Annual Review of Public Health, 2005; 26: 319–339. [DOI] [PubMed] [Google Scholar]
  • 24. Eadie D, MacKintosh A, MacAskill S, Brown A. Development and evaluation of an early detection intervention for mouth cancer using a mass media approach. British Journal of Cancer, 2009; 101: S73–S79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Guyatt G, Oxman A, Vist G, Kunz R, Falck‐Ytter Y, Schunemann H. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal, 2008; 336: 924–926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Chen MY, Karvelas M, Sundararajan V, Hocking JS, Fairley CK. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection. International Journal of STD and AIDS, 2007; 18: 239–243. [DOI] [PubMed] [Google Scholar]
  • 27. Wilkins A, Mak D. Sending out an SMS: an impact and outcome evaluation of the Western Australian Department of Health's 2005 chlamydia campaign. Health Promotion Journal of Australia, 2007; 18: 113–120. [DOI] [PubMed] [Google Scholar]
  • 28. Gaydos CA, Barnes M, Aumakhan B et al Can E‐technology through the internet be used as a new tool to address the chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sexually Transmitted Diseases, 2009; 36: 577–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Gaydos CA, Dwyer K, Barnes M et al Internet‐based screening for Chlamydia trachomatis to reach non‐clinic populations with mailed self‐administered vaginal swabs. Sexually Transmitted Diseases, 2006; 33: 451–457. [DOI] [PubMed] [Google Scholar]
  • 30. van Bergen JE, Fennema JS, van den Broek IV et al Rationale, design, and results of the first screening round of a comprehensive, register‐based, Chlamydia screening implementation programme in the Netherlands. BMC Infectious Diseases, 2010; 10: 293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. van den Broek IV, Hoebe CJ, van Bergen JE et al Evaluation design of a systematic, selective, internet‐based, Chlamydia screening implementation in the Netherlands, 2008‐2010: implications of first results for the analysis. BMC Infectious Diseases, 2010; 10: 89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Anderson C, Thornley T. A pharmacy‐based private chlamydia screening programme: results from the first 2 years of screening and treatment. International Journal of Clinical Pharmacy, 2011; 33: 88–91. [DOI] [PubMed] [Google Scholar]
  • 33. Emmerton L, Skinner M, Gardiner E, Nissen L, Debattista J. A trial of the distribution of Chlamydia self‐collection postal specimen kits from Australian community pharmacies. Sexual Health, 2011; 8: 130–132. [DOI] [PubMed] [Google Scholar]
  • 34. van Bergen J, Postma MJ, Peerbooms PGH, Spangenberg AC, Tjen‐A‐Tak J, Bindels PJE. Effectiveness and cost‐effectiveness of a pharmacy‐based screening programme for Chlamydia trachomatis in a high‐risk health centre population in Amsterdam using mailed home‐collected urine samples. International Journal of STD & AIDS, 2004; 15: 797–802. [DOI] [PubMed] [Google Scholar]
  • 35. Brabin L, Thomas G, Hopkins M, O'Brien K, Roberts SA. Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health, 2009; 9: 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Alicea‐Alvarez N, Hellier SD, Jack LW, Lundberg GG. A pilot study of chlamydia screening among high school girls. Journal for Nurse Practitioners, 2011; 7: 25–28. [Google Scholar]
  • 37. Barry PM, Scott KC, McCright J et al Stay in school? Results of a sexually transmitted diseases screening program in San Francisco high schools‐2007. Sexually Transmitted Diseases, 2008; 35: 550–552. [DOI] [PubMed] [Google Scholar]
  • 38. Aldeen T, Jacobs J, Powell R. Screening university students for genital chlamydial infection: another lesson to learn. Sexual Health, 2010; 7: 491–494. [DOI] [PubMed] [Google Scholar]
  • 39. Vaughan D, O'Connell E, Cormican M et al “Pee‐in‐a‐Pot”: acceptability and uptake of on‐site chlamydia screening in a student population in the Republic of Ireland. BMC Infectious Diseases, 2010; 10: 325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Chai SJ, Aumakhan B, Barnes M et al Internet‐based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sexually Transmitted Diseases, 2010; 37: 756–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Andersen B, Olesen F, Moller JK, Ostergaard L. Population‐based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. Journal of Infectious Diseases, 2002; 185: 252–258. [DOI] [PubMed] [Google Scholar]
  • 42. Jones HE, Altini L, de Kock A, Young T, van de Wijgert J. Home‐based versus clinic‐based self‐sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial. Sexually Transmitted Infections, 2007; 83: 552–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Kwan K, Jachimowicz E, Bastian L, Marshall L, Mak D. Online chlamydia testing: an innovative approach that appeals to young people. Medical Journal of Australia, 2012; 197: 287–290. [DOI] [PubMed] [Google Scholar]
  • 44. Sacks‐Davis R, Gold J, Aitken CK, Hellard ME. Home‐based chlamydia testing of young people attending a music festival–who will pee and post? BMC Public Health, 2010; 10: 376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM. Population‐based outreach for Chlamydia screening in men: results from a randomized trial. Sexually Transmitted Diseases, 2007; 34: 837–839. [DOI] [PubMed] [Google Scholar]
  • 46. Oh MK, Grimley DM, Merchant JS, Brown PR, Cecil H. Hook Iii EW. Mass media as a population‐level intervention tool for Chlamydia Trachomatis screening: report of a pilot study. Journal of Adolescent Health, 2002; 31: 40–47. [DOI] [PubMed] [Google Scholar]
  • 47. Novak DP, Karlsson RB. Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study. Sexually Transmitted Infections, 2006; 82: 142–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. National Centre in HIV Epidemiology and Clinical Research . HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2009. Sydney, NSW: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 2009. [Google Scholar]

Articles from Health Expectations : An International Journal of Public Participation in Health Care and Health Policy are provided here courtesy of Wiley

RESOURCES